State Street SPDR S&P Biotech ETF (XBI) — ()
Key Metrics
News
Final Trades: FTAI, ETN, COWZ, XBI
Published: by:
Sentiment: Neutral ()
The Investment Committee give you their top stocks to watch for the second half.
Read More
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
Published: by:
Sentiment: Positive ()
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the …
Read More
Biotech ETF (XBI) Hits New 52-Week High
Published: by:
Sentiment: Positive ()
XBI hits a fresh 52-week high after a sharp rebound in biotech momentum fueled by favorable regulation, valuations and improving funding trends.
Read More
Final Trades: Taiwan Semi, HealthEquity, CBOE Global Markets and the XBI
Published: by:
Sentiment: Neutral ()
The Investment Committee give you their top stocks to watch for the second half.
Read More
3 Biotech Stocks I Am Accumulating
Published: by:
Sentiment: Positive ()
The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good …
Read More
RTW Investments' Rod Wong: Expect more deals in biotech space
Published: by:
Sentiment: Positive ()
Rod Wong, RTW Investments CIO & Managing Director, joins CNBC's 'Money Movers' to discuss J&J's reported interest in buying Protagonist Therapeutics, whether he expects more consolidation in the sector, and …
Read More
Trade Tracker: Joe Terranova buys more XBI
Published: by:
Sentiment: Positive ()
Joe Terranova, senior managing director at Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying XBI again. The committee share their health care strategy.
Read More
How to trade the health care break out
Published: by:
Sentiment: Positive ()
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
Read More
XBI: Surprise Exit Of A Tough Regulator At The FDA
Published: by:
Sentiment: Neutral ()
XBI has rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a tougher regulatory environment. Vinay Prasad was only appointed in May, but …
Read More
Trump threatens 50% tariffs on copper, 200% on pharmaceuticals
Published: by:
Sentiment: Neutral ()
However, the President did not disclose when the tariffs would take effect.
Read More
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
Published: by:
Sentiment: Neutral ()
President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly …
Read More
Surprise Breakthrough: US-China Talks Spark Market Rally
Published: by:
Sentiment: Positive ()
An unexpected thaw in US-China trade relations is sending US equity markets soaring this morning.
Read More
Trade Tracker: Joe Terranova sells the XBI, buys Amgen
Published: by:
Sentiment: Neutral ()
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.
Read More